MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Accuracy of the Tanner’s Questionnaire and the REM Sleep Behavior Disorder Single-Question Screen as Screening Tools for Parkinson’s Disease in a Brazilian Cohort

    G. Bolner, G. Magalhães Pereira, N. Medeiros Soares, C. Cenci Sangali, D. Dos Santos, T. de Carvalho, C. Mello Rieder, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: Assess the Tanner’s Questionnaire (TQ) and the REM Sleep Behavior Disorder Single-Question Screen (RBD1Q) performance as screening tools for Parkinson’s Disease (PD) in a…
  • 2025 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study

    A. Haque, K. Dey, T. Zannat, A. Zirra, E. Camboe, S. Waters, D. Mair, T. Haque, C. Marshall, R. Weil, N. Mukadam, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: This study aimed to evaluate the prevalence of CI in a diverse group of patients with PD in Dhaka, Bangladesh. This study also aimed…
  • 2025 International Congress

    Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson’s Disease: A PPMI-based study

    A. Negida, M. Barrett, SM. Fereshtehnejad, B. Berman, N. Mukhopadhyay (Toronto, Canada)

    Objective: To enable prospective identification of individuals with diffuse malignant (DM) Parkinson’s disease (PD) by establishing disease-duration-specific thresholds for motor and non-motor symptom scales. Background:…
  • 2025 International Congress

    Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

    E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

    Objective: 1-Comparing the risk of prodromal PD between AO exposed veterans (AOEV) and non-AO exposed veterans without PD (Controls) in a Veterans Affairs (VA) hospital…
  • 2025 International Congress

    Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks

    M. Farghaly, H. Khabiry, O. Sabry, A. Nagah, O. Awadalla, M. Elsayed (Giza, Egypt)

    Objective: To evaluate multidisciplinary approaches to palliative care in late-stage Parkinson’s disease (PD) and assess the effectiveness of educational tools and frameworks in improving patient…
  • 2025 International Congress

    Family History of Parkinson’s Disease in Patients with Essential Tremor and in Patients with Parkinson’s Disease and Its Association with Different Phenotypes.

    R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

    Objective: To clinically and phenotypically describe essential tremor (ET) and parkinson's disease (PD) patients and compare their familial histories in first- and second-degree relatives.. Background:…
  • 2025 International Congress

    Risk factors in a population with high prevalence of Parkinson’s disease in Chile

    ME. Contreras Pinto, U. Hernandez Villarroel, N. Angel, F. Pancetti Vaccari, B. Soto, M. Ramirez, M. Vera Amoroso, J. Otero Olmos, G. Oneto Diaz, C. Morales (la serena, Chile)

    Objective: The aim of this study was to investigate the frequency of environmental risk factors, comorbidities and family history in a population with Pakinson disease…
  • 2025 International Congress

    Perceived Versus Actual Performance During Dual-Task Walking: Insights from Parkinson’s Disease

    H. Johansson, B. Leavy (Stockholm, Sweden)

    Objective: To explore the concordance between perceived difficulty and focus, to actual performance during a dual-task (DT) two-minute walk test (2MWT) in people with Parkinson’s…
  • 2025 International Congress

    Association Between Depression and Sleep Disorders in Parkinson’s Disease

    J. Jiang, W. Wu, M. Mao (Suzhou, China)

    Objective: To investigate the clinical characteristics of depression in Parkinson’s disease (PD) and its correlation with sleep disorders. Background: PD is the second most common…
  • 2025 International Congress

    Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion

    A. Zhao, Y. Jiao, J. Liu, Y. Li (shanghai, China)

    Objective: DJ-1, also known as Parkinson's disease protein 7 (PARK7), is a multifunctional protein that is important in regulating oxidative stress and neuroprotection. Background: The…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley